$LH News

Will Labcorp (LH) Beat Estimates Again in Its Next Earnings Report?

Labcorp Holdings: The Story Has Not Changed Materially

B of A Securities Maintains Buy on Labcorp Holdings, Raises Price Target to $320

Baird Maintains Outperform on Labcorp Holdings, Raises Price Target to $338

Labcorp Declares Quarterly Dividend

Here's What to Expect From Labcorp Holdings’ Next Earnings Report

LH or CRL: Which Is the Better Value Stock Right Now?

Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026

Why Labcorp (LH) Is Up 6.1% After FDA Approval, Medicare Coverage Of ColoSense At-Home Test

Q1 Earnings Highlights: Labcorp (NYSE:LH) Vs The Rest Of The Testing & Diagnostics Services Stocks

Is it the Right Time to Add Labcorp Stock to Your Portfolio?

3 Reasons LH is Risky and 1 Stock to Buy Instead

Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test

Labcorp Announces Nationwide Availability Of ColoSense, Its RNA-Based, At-Home Colorectal Cancer Screening Test

LH vs. CRL: Which Stock Is the Better Value Option?

Labcorp Holdings Inc. (LH) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Assessing Labcorp (LH) Valuation As Shares Cool And P/E Trails Healthcare Peers

LH Expands Genetic Testing in CRC Through New Collab: Stock to Gain?

Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer

Labcorp Enters Collaboration The Alliance For Clinical Trials In Oncology To Advance A National, Multicenter Clinical Trial For Patients Newly Diagnosed With Colorectal Cancer